| тип : |
Лаборатория |
|
| Исследовательские группы : |
|
| Авторы : |
|
| Заголовок : |
Avelumab (Bavencio®) - Summary of Product Characteristics |
| Номер : |
Merck 2023 |
|
| Уровень доказательности : |
|
| Физическая стабильность : |
|
| Химическая стабильность : |
|
| Другие методы : |
|
| Комментарии : |
|
Списки
 Avelumab
|
 |
 |
 |
 |
3.2 mg/mL |
2-8°C |
 |
| 96 |
 |
|
|
|
|
|
3.2 mg/mL |
20-25°C |
 |
| 72 |
|
|
|
|
|
 |
3.2 mg/mL |
2-8°C |
|
| 24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 24 |
|
|
|
|
 |
|
3.2 mg/mL |
2-8°C |
|
| 96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
| 24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 24 |
|
|
|
|
 |
|
3.2 mg/mL |
2-8°C |
|
| 96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
| 24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 24 |
|
|
|
|
 |
|
3.2 mg/mL |
2-8°C |
|
| 96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
| 24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 24 |
|
|
|
|
 |
|
3.2 mg/mL |
2-8°C |
|
| 96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
| 24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
| 24 |
|
|
|
|
|
| |
+
|
|
|
|
|
| |
+
|
|
|
|
